Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB1 | P23443 | 16/20 | 0.52 |
| ▸ | AKT1 | P31749 | 16/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.46 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.46 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.43 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2063633 | 0.93 | RPS6KB1 (0.51) | RPS6KB1AKT1MAPTCNR1NPSR1 | |
| SCHEMBL2063679 | 0.91 | RPS6KB1 (0.51) | RPS6KB1AKT1MAPTCNR1NPSR1 | |
| SCHEMBL2063243 | 0.90 | RPS6KB1 (0.49) | RPS6KB1AKT1MAPTCNR1NPSR1 | |
| SCHEMBL11904398 | 0.90 | RPS6KB1 (0.65) | RPS6KB1AKT1 | |
| SCHEMBL11904316 | 0.89 | RPS6KB1 (0.53) | RPS6KB1AKT1MAPTCNR1NPSR1 | |
| SCHEMBL2062977 | 0.89 | RPS6KB1 (0.51) | RPS6KB1AKT1 | |
| SCHEMBL11904260 | 0.88 | RPS6KB1 (0.60) | RPS6KB1AKT1 | |
| SCHEMBL2064139 | 0.86 | RPS6KB1 (0.46) | RPS6KB1AKT1MAPTCNR1NPSR1 | |
| SCHEMBL2064061 | 0.85 | GPR119 (0.44) | RPS6KB1AKT1MAPTCNR1NPSR1 | |
| SCHEMBL2064656 | 0.85 | GPR119 (0.47) | RPS6KB1AKT1MAPTCNR1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2358710-B1 | AKT AND P70 S6 KINASE INHIBITORS | LILLY CO ELI (US) | 2012-08-15 | — | — | EP | disclosed |